Amal El‐Beshlawy

A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease

Elliott Vichinsky, Carolyn Hoppe, Kenneth I. Ataga et al. · New England Journal of Medicine · 2019 · 609 citations · Full text

Medicine, Hematology, Hematopathology +8

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A

Flora Peyvandi, Pier Mannuccio Mannucci, Isabella Garagiola et al. · New England Journal of Medicine · 2016 · 491 citations · Full text

Medicine, Hematology, Immunology +16

Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study

Alì Taher, Khaled M. Musallam, Mehran Karimi et al. · Blood · 2009 · 380 citations

Medicine, Hematology, Internal Medicine +11

Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias

Maria Domenica Cappellini, John B. Porter, Amal El‐Beshlawy et al. · Haematologica · 2009 · 287 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Updates in Hemoglobinopathies

Youssef Al‐Tonbary, Fernando Tricta, Amal El‐Beshlawy et al. · The Scientific World JOURNAL · 2013 · 221 citations · Full text

Medicine, Botany, Hematology +17